|Positive WB detected in||Raji cells, RAW 264.7 cells, human peripheral blood leukocyte, Ramos cells|
|Positive FC detected in||Raji cells|
|Western Blot (WB)||WB : 1:500-1:2000|
|Sample-dependent, check data in validation data gallery|
14292-1-AP targets CD80/B7-1 in WB, IHC, IF, FC, Cell treatment, ELISA applications and shows reactivity with human, mouse samples.
|Tested Reactivity||human, mouse|
|Cited Reactivity||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||CD80/B7-1 fusion protein Ag5615|
|Full Name||CD80 molecule|
|Calculated molecular weight||33 kDa|
|Observed molecular weight||60 kDa|
|GenBank accession number||BC042665|
|Gene ID (NCBI)||941|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
CD80 (also known as B7-1) is a type I membrane protein that is a member of the immunoglobulin superfamily, with an extracellular immunoglobulin constant-like domain and a variable-like domain required for receptor binding. It is expressed on antigen-presenting cells (APCs), including B cells, dendritic cells, monocytes, and macrophages. CD80 is the receptor for the proteins CD28 and CTLA-4 found on the surface of T-cells. It is involved in the costimulatory signal essential for T-lymphocyte activation. T-cell proliferation and cytokine production is induced by the binding of CD28, binding to CTLA-4 has opposite effects and inhibits T-cell activation. CD80 also acts as a cellular attachment receptor for adenovirus subgroup B. (PMID: 7545666; 12015893; 16920215)
Light-controlled oxygen production and collection for sustainable photodynamic therapy in tumor hypoxia.
Photosynthetic microorganisms coupled photodynamic therapy for enhanced antitumor immune effect.
Continuous ZnO nanoparticle exposure induces melanoma-like skin lesions in epidermal barrier dysfunction model mice through anti-apoptotic effects mediated by the oxidative stress-activated NF-κB pathway.
Sonosensitizer nanoplatform-mediated sonodynamic therapy induced immunogenic cell death and tumor immune microenvironment variation.
J Transl Med
Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients.
ACS Appl Mater Interfaces
Fe(III)-Chelated Polydopamine Nanoparticles for Synergistic Tumor Therapies of Enhanced Photothermal Ablation and Antitumor Immune Activation.